Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Pediatric Acne, Acne-Related Conditions, Isotretinoin Management, and Social Media Skincare Trends

Description

The speaker reviewed pediatric acne by age group, stressing important distinctions: neonatal acne usually resolves on its own but can be treated with ketoconazole if parents want; toddler acne (6 to 18 months) is more inflammatory, can scar, and may need treatment such as clindamycin, benzoyl peroxide/clindamycin, adapalene, oral antibiotics, or rarely isotretinoin; mid-childhood acne (ages 3 to 7) warrants evaluation for underlying causes such as inhaled steroids or endocrine issues; and acne in children 7 to 9 is increasingly considered normal because puberty is starting earlier, likely due to obesity, endocrine-disrupting chemicals, and stress. She then focused on isotretinoin management, recommending treatment until the target cumulative dose is reached and the patient has been completely clear for at least one month, optimizing absorption with fatty food, considering lido tech formulations, extractions for comedones, alternate dosing or generics, and hormonal add-ons in girls. She discussed side effects and myths, saying depression is rare but real in some patients, mood changes can occur, and “purge” reactions can often be prevented or managed with lower starting doses, prednisone, or sometimes antibiotics; she also addressed paronychia, noting dose reduction, topical steroids, cephalexin, and topical timolol can help. The talk also covered acne-related conditions such as perioral dermatitis, nasal demodex-associated disease, and idiopathic facial aseptic granuloma, highlighting pediatric-specific treatments like calcineurin inhibitors, amoxicillin or azithromycin, permethrin, metronidazole, ivermectin, and hypochlorous acid. In closing, she criticized social media skincare trends and aggressive marketing to children and tweens, warning about unnecessary products, body-image pressure, and financial burden while noting a few trends with limited evidence, such as spearmint tea and oral probiotics, and urging clinicians to understand the online landscape so they can counsel families effectively.

View more

Conclusions

  • Neonatal acne is usually self-limited and generally does not require treatment, though antifungal therapy may be used if families want to intervene.
  • Toddler acne should be treated rather than dismissed because it is more inflammatory, starts later than neonatal acne, and can scar.
  • Acne beginning in mid-childhood warrants evaluation for underlying causes such as steroid exposure or endocrine abnormalities.
  • Earlier onset of “teenage” acne appears to reflect earlier puberty, which may be influenced by obesity, endocrine-disrupting chemicals, and stress.
  • Isotretinoin is highly effective, and treatment should continue until the target cumulative dose is reached and the patient is fully clear.
  • If isotretinoin response is inadequate, adherence, absorption with fatty food, formulation choice, dosing strategy, and adjunctive therapies should be checked and optimized.
  • The best available population-level evidence suggests isotretinoin is not associated with increased depression, but rare serious mood changes can occur in individual patients.
  • A subset of patients on isotretinoin may experience a predictable early “purge,” which can often be prevented or managed with low-dose starts and anti-inflammatory support.
  • Isotretinoin can also cause inflammatory paronychia and other nuisance side effects that are usually managed by dose reduction and medical therapy rather than surgery.
  • Perioral dermatitis in children is common, often recurrent, and usually responds well to topical therapy or other non-tetracycline options.
  • Facial papules plus nasal pustules in children should raise suspicion for demodex-associated disease, which may require permethrin, metronidazole, ivermectin, or similar therapies.
  • Social media and the pediatric skincare market are strongly influencing families, often promoting expensive or unnecessary products to very young patients.
  • A large share of acne content online is created by non-dermatologists, so misinformation and overhyped advice are common.
  • Many viral skincare trends, such as glass skin, slugging, and some aggressive cleansing routines, can irritate skin or worsen acne rather than improve it.
  • Some online acne advice has limited evidence, with a few options like spearmint tea or probiotics showing possible benefit but needing more robust study.
  • Clinicians should actively discuss skincare trends with families, meet them halfway, and guide them toward treatments that are effective, safe, and not wasteful.
  • Howard S. Timing of puberty: why is it changing and why does it matter? The Endocrinologist. Winter 2019, Issue 134.
  • Douglas, A and Zaenglein AL. A case series of demodicosis in children. Pediatr Dermatol. 2019; 36:651-654.#10.1111/pde.13852
  • Keller Goff, Gabrielle and Sarah Stein. Cosmeceuticals in the Pediatric Population Part II: Ethical Dilemmas and Patient Talking Points. Ped Derm, 2025; 42: 228-232.#10.1111/pde.15867
  • Keller Goff, Gabrielle and Sarah Stein. Cosmeceuticals in the Pediatric Population Part I: A Review of Risks and Available Evidence. Ped Derm, 2025; 42: 221-27.#10.1111/pde.15866
  • Hunt et al., Skinfluencers: Investigating the Safety and Efficacy of Consumer to Consumer Advice on Social Media for the Treatment of Acne Vulgaris, Journal of Integrative Dermatology, published online 2025.
  • Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine, JAMA Dermatology.#10.1001/jamadermatol.2017.4120